Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Quantum BioPharma Ltd.
QNTMCurrent price
5.44 USD
+0.5 USD (+10.12%)
Last closed
4.88 USD
Company
–
ISIN
unknown
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Capitalization
6 171 661 USD
Yield for 12 month
-92.18 %
1Y
3Y
5Y
10Y
15Y
QNTM
Quantum BioPharma Ltd., a biopharmaceutical company, researches and develops a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company operates through two segments, Biopharmaceutical and Strategic Investments. Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company is also developing a treatment for alcohol misuse for application in hospitals and other medical practices. In addition, it maintains a portfolio of strategic investments comprising loans secured by residential property. The company was formerly known as FSD Pharma Inc. and changed its name to Quantum BioPharma Ltd., in August 2024. Quantum BioPharma Ltd., is headquartered in Toronto, Canada. Address: 55 University Ave., Toronto, ON, Canada, M5J 2H7
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
169 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Key Figures QNTM
1 year
3 years
5 years
10 years
EBITDA
-10 064 798 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-36.12 %
PEG Ratio
–
Return On Equity TTM
-63.89 %
Wall Street Target Price
169 USD
Revenue TTM
–
Book Value
15.02 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-13 USD
Diluted Eps TTM
-13 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics QNTM
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History QNTM
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:65
Payout Ratio
–
Last Split Date
15.08.2024
Dividend Date
–
Stock Valuation QNTM
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
98.5599
Price Sales TTM
91.8563
Enterprise Value EBITDA
-1.5744
Price Book MRQ
0.5527
Financials QNTM
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators QNTM
For 52 weeks
3.5 USD
97.5 USD
50 Day MA
6.54 USD
Shares Short Prior Month
95 094
200 Day MA
33.64 USD
Short Ratio
0.22
Shares Short
10 086
Short Percent
8.53 %
BeatStart